Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1 to 25 of about 5807

Website Changes

07/22/2024

Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated BBB opening: a novel combinatorial immunotherapy regimen for gliomas

07/22/2024

Duke Phase 2 poliovirus trial for recurrent glioblastoma open for enrollment

07/22/2024

Webinar on LTSL-Dox plus Hyperthermia now available

07/22/2024

Update from our friends at Roon!

07/15/2024

Musella Foundation Is Now Accepting Cryptocurrency Donations

07/15/2024

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022

07/12/2024

Expanded Access Program for gallium maltolate (GaM) Now Open

07/08/2024

Musella Foundation Copay Assistance Program is now open!

07/01/2024

Application of Delta T1 maps for quantitative and objective assessment of extent of resection and survival prediction in glioblastoma

07/01/2024

No benefit from TMZ treatment in GB with truly unmethylated MGMT promotor: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB

07/01/2024

Exhaustive in vitro evaluation of the 9-drug cocktail CUSP9 for treatment of glioblastoma

07/01/2024

Musella Foundation Awards Research Grant

06/23/2024

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park

06/13/2024

Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeting

06/12/2024

Musella Foundation Earns a Four-Star Rating From Charity Navigator

06/03/2024

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

06/03/2024

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival

06/03/2024

Brain Cancer Support and Solutions Alliance Launched to Improve Care and Outcomes for Brain Tumor Patients

06/03/2024

For Love & Life: No Ordinary Campaign

05/28/2024

Introducing Promising Pathway 2.0

05/28/2024

Brain Tumor Awareness Month Webinar Series

05/28/2024

Musella Foundation Awards 3 Research Grants!

05/27/2024

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

05/27/2024

Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients

05/23/2024

IMVAX Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful Financing

Our privacy / cookie policy has changed.
Click HERE to read it!